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Abstract
Background/Aims: During peritoneal equilibrium test (PET), intermediate measures of Dt/P 
(dialysate / plasma creatinine ratio), D0/P, D2/P and D4/P ratios might provide additional 
information regarding a patient’s cardiovascular mortality. We aimed to characterise 
heterogeneity of dialysate creatinine response patterns based on three ratios and compare 
cardiovascular mortality risks by response patterns. Methods: 3,477 patients initialising 
peritoneal dialysis (PD) between 2007-2015 were measured D0/P, D2/P and D4/P at baseline 
and 2-year cardiovascular mortality was defined as the primary outcome. Latent class 
mixed-effect models were fitted to identify distinct patterns of dialysate creatinine response. 
Multivariable Logistic regression model with adjustment of cardiometabolic factors were used 
to compare cardiovascular mortality by latent classes. Results: The 1st latent class including 
36% of participants was characterised by consistently increasing and high Dt/P ratios both 
at 2-hour and 4-hour. The 2nd class including 61% of participants characterised by sharply 
increased ratio at 2-hour and slightly increased ratio at 4-hour. The 3rd class included 3% 
of participants with decreased ratio at 2-hour and increased ratio at 4-hour. Comparing the 
1st class, the lower cardiovascular mortality risk was identified in the 2nd and 3rd class with 
adjusted odds ratio 0.65 (95% confidence interval: 0.62-0.69) and 0.48 (0.41-0.57), respectively. 
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Conclusion: Patients with decreased Dt/P ratio between 0-hour and 2-hour and low ratios at 
2-hour and 4-hour tend to have low cardiovascular mortality. Latent class analysis seems to 
be a promising method to reveal unidentified subgroups that do not fit into the risk category 
defined by Dt/P ratio at 4-hour.
IntroductionChronic kidney disease (CKD) has become a worldwide heath problem [1]. In particular, end-stage renal disease (ESRD) triggers premature mortality and a substantial health economic burden [2]. It has been estimated that more than 10.8% of Chinese adults (around 130 million) have CKD with dialysis needs at some point in their lives [3]. Increased coverage of Chinese medical insurance has made dialysis, especially peritoneal dialysis (PD), more affordable among Chinese patients with ESRD [4]. The leading cause of mortality among people accepting PD is cardiovascular disease (CVD) [5].Patients treated with PD usually undergo a peritoneal equilibration test (PET) to characterize the rate of transfer of solute and water across the peritoneal barrier [6]. The test yields three parameters—4-hour dialysate to plasma ratio of creatinine (D/P creatinine), 4- 
to 0-hour dialysate glucose ratio (D/D0 glucose), and 4-hour ultrafiltration volume (UFV) [6]. Although the results of the PET can help optimize solute clearances, they are more 
often used to individualize PD prescriptions to maximize daily peritoneal ultrafiltration [7, 8]. Indeed, the higher risk for death or transfer to hemodialysis in individuals with faster 
solute transfer rate is thought to result from volume overload from challenges with fluid removal with continuous ambulatory PD in such patients [9]. Previous studies investigated the all-cause mortality and hospitalization risk using the three measurements at 4-hour [10]. It is unclear whether there is heterogeneity in measurement response curves during 
the PET is an alternative approach to identify a range of features that may reflect underlying 
pathophysiological mechanisms. Dialysate creatinine response reflecting the creatinine metabolism status associated with future risk of cardiovascular mortality has not been 
examined. Furthermore, investigating whether different dialysate creatinine response curves 
during the PET represent distinct cardiovascular risk profiles may contribute to elucidate the heterogeneity in the underlying pathophysiological pathways to cardiovascular mortality.Now, we proposed latent class analyses to reveal heterogeneity in dialysate creatinine response patterns based on three time points (0-hour, 2-hour and 4-hour) during the PET, 
and thereafter compare the cardiovascular mortality rate between the identified latent classes. We hypothesise that there will be individuals at high risk not captured by classical one-time measures of risk.
Materials and Methods
Data Setting
The data used in this study was derived from the Henan Peritoneal Dialysis Registry (HPDR). Briefly, 
the HPDR is operated under the auspices of the Department of Nephrology, the First Affiliated Hospital of 
Zhengzhou University and provides an independent audit and analysis of renal care in Henan, China. During the study period, information was prospectively collected electronically from all renal units across Henan. 
Data arriving at the HPDR are subjected to an algorithm which identifies suspicious values, which are then 
further verified and corrected where necessary by contacting the renal unit.
Study populationThis study was designed as a cohort study, which included all adults aged more than 18 years 
who commenced PD between 2007-2015 and who had at least two years’ follow-up. Patients who died, underwent transplant or whose kidney function recovered within 90 days after initialisation of dialysis 
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(n=16) were excluded to avoid a reverse causality association between predictors and outcome. This reflects the standard approach to investigate “real” ESRD patients among all those receiving PD care.
Outcomes
The primary outcome of this study was defined as cardiovascular mortality. Cases were defined as 
deceased patients, on the HPDR, with CVD as the cause of death based on the diagnosis on death certificate.
PET Test and dialysate creatinine measurementsA standard PET was performed; dialysate samples were collected at times 0, 2-hour, and 4-hour, and a blood sample was collected at 120 minutes. All blood and dialysate samples were analysed within 24 hours. Three dialysate / plasma creatinine ratios: D0/P ratio (0-hour dialysate creatinine / plasma creatinine), D2/P ratio (2-hour dialysate creatinine / plasma creatinine) and D4/P ratio (4-hour dialysate creatinine / plasma creatinine) were used to quantify the dialysate creatinine response.
Ethics approval was granted by the Clinical Research Ethics Committee of the First Affiliated Hospital 
of Zhengzhou University. Written informed consent was obtained from all participants before inclusion.
CovariablesAll available information, including comorbidities, demographic characteristics, and clinical measurements were collected at the time of patients initialising PD.
Statistical AnalysisWe used latent class trajectory analysis to identify heterogeneous dialysate creatinine response patterns during the PET. Latent class growth analysis is a semi-parametric statistical technique that aims to model individual trajectories over time using polynomial curves after accounting for unobserved heterogeneity 
within the population [11, 12]. A search for the optimum latent class growth model was conducted by fitting 
a one-class linear model to the data and then successively increasing the number of classes until model fit 
no longer improved. Model fit was based on statistical criteria (Bayesian information criterion (BIC)) and on 
a judgement of model interpretability [12]. In our study, the latent class mixed-effects model was specified 
with linear, quadratic and cubic time terms to model non-linear change over time [13-15]. Coefficients 
were allowed to vary between latent groups. After determining the best fitting model, each individual was assigned to the creatinine response pattern group (latent class) with the highest membership probability.We then described the cardiometabolic characteristics (age, sex, smoking status, body mass index, 
lipid profile, phosphorus, estimated Glomerular Filtration rate and blood pressure) of study participants 
stratified by latent class.Logistic regression models with adjustment for two sets of variables were used to compare risk of cardiovascular mortality between latent classes. Model 1 was adjusted for age and gender. Model 2 was additionally adjusted for other variables presented in Table 1.Missing information was as follows: BMI (10.51%), phosphate (10.23%), albumin (9.92%), total 
protein (12.75%), total cholesterol (14.53%), low density lipoprotein (14.58%), high density lipoprotein (14.52%), triglyceride (14.52%), fasting glucose (15.26%), SBP (2.26%), and DBP (2.23%). We used multiple imputation to replace missing values by using a chained equation approach based on all candidate predictors. We created 15 imputed datasets for missing variables that were then combined across all 
datasets by using Rubin’s rule to obtain estimations.
All analyses were performed using STATA (STATA/SE 14.0 StataCorp, College Station, TX, USA). All P 
values were calculated using two-tailed tests and a P value < 0.05 was taken to indicate statistical significance.
Results
Three latent classes were identified, each including 36.1%, 61.2%, and 2.7% of the study 
population (Fig. 1). Average posterior group membership probabilities were high, ranging between 0.85–0.96, indicating a good discrimination between the groups.
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Class 1 and class 2 both demonstrated the lowest D0/P ratio (0.123 (95% confidence interval (CI) 0.121, 0.124) for class 1 and 0.094 (0.093, 0.095) for class 2) and dramatic 
increase over the following 2 hours (0.591 (0.589, 0.594) for class 1 and 0.416 (0.414, 0.417) for class 2) and 4 hours (0.852 (0.850, 0.855) for class 1 and 0.638 (0.636, 0.640) for class 2). Class 3 presented distinctively different trajectory from class 1 and 2, as higher ratio 
at 0 hour (0.832 (0.827, 0.837)) and dramatically decreased ratio at 2 hour (0.480 (0.475, 
0.484)) and increased ratio at 4 hour (0.696 (0.692, 0.701)) (Fig. 1).
Characteristics of study participants stratified by latent classes are shown in Table 1. 
Class 1, characterised by the lowest median age (47 years), the highest proportion of male gender (63.3%), the highest prevalence of previous diagnosed cardiovascular diseases 
(67.4%), the lowest median estimated glomerular filtration rate (eGFR) (1.3ml/min/1.73m2), the lowest median prealbumin (311.4 mg/dl) and the highest median C-reaction protein (CRP) (2.3 mg/dl).
Table 1. Cardiometabolic risk factor characteristics by latent class. Binary variables are displayed as numbers (percentage) and continuous variables are displayed as median (interquartile range). Variables 
were compared between latent groups using Kruskal-Wallis tests for continuous variables and χ2 tests for 
categorical variables. For all differences, p-values were <0.001
 
1 
 
    Characteristics Overall Class 1 Class 2 Class 3 N 3,477 1,255 2,127 95 Male Gender, n (%) 2,050 (59.0) 795 (63.3) 1,204 (56.6) 51 (53.5) Cardiovascular diseases, n (%) 1,586 (45.6) 846 (67.4) 709 (33.3) 31 (32.6) Taking antihypertensive treatment, n (%) 1,433 (41.2) 559 (44.5) 830 (39.0) 44 (46.3) Age (years) 48.0 (38.0, 59.0) 47.0 (38.0, 58.0) 49.0 (38.0, 59.0) 51.0 (45.0, 62.0) Body mass index (kg/m2) 22.8 (20.8, 24.9) 22.5 (20.7, 24.9) 22.9 (20.8, 25.0) 22.4 (20.1, 24.6) Total cholesterol (mmol/L) 4.5 (3.7, 5.2) 4.4 (3.6, 5.2) 4.5 (3.7, 5.2) 4.6 (4.2, 5.2) Low density lipoprotein -cholesterol (mmol/L) 2.6 (2.0, 3.2) 2.5 (2.0, 3.2) 2.6 (2.1, 3.2) 2.6 (2.1, 3.0) High density lipoprotein -cholesterol (mmol/L) 1.1 (1.0, 1.4) 1.2 (1.0, 1.4) 1.1 (1.0, 1.3) 1.2 (0.8, 1.6) Triglyceride (mmol/L) 1.2 (1.0, 1.8) 1.2 (0.9, 1.6) 1.3 (1.0, 1.9) 1.1 (0.8, 1.2) Systolic blood pressure (mmHg) 142.0 (133.0, 155.0) 145.0 (135.0, 159.0) 140.0 (132.0, 152.0) 147.5 (135.0, 160.0) Diastolic blood pressure (mmHg) 86.0 (80.0, 94.0) 87.0 (80.0, 93.0) 85.0 (80.0, 94.0) 90.0 (80.0, 100.0) Haemoglobin, g/L 94.0 (80.0, 108.0) 91.0 (78.0, 106.0) 95.0 (81.0, 108.0) 97.0 (77.3, 107.0) Reticulocyte, %  44.2 (17.2, 69.1) 44.6 (20.0, 67.2) 45.6 (18.9, 77.0) 45.2 (50.0, 71.0) Phosphorus, mg/dl 1.7 (1.4, 2.1) 1.7 (1.3, 2.0) 1.7 (1.4, 2.1) 1.9 (1.5, 2.2) Albumin, g/L 34.0 (30.2, 38.0) 32.6 (29.0, 36.2) 34.6 (31.0, 38.6) 34.3 (28.3, 38.3) Total iron binding capacity , μmol/L 46.7 (36.2, 52.3) 46.7 (36.2, 52.7) 47.1 (36.7, 52.2) 49.0 (35.0, 58.9) Creatinine, µmol/L 872.0 (687.1, 1093.0) 884.8 (685.0, 1117.0) 866.0 (690.0, 1069.9) 824.0 (620.0, 916.1) estimated Glomerular Filtration rate, mL/min/1.73 m2 1.5 (0.4, 3.3) 1.3 (0.4, 2.9) 1.7 (0.5, 3.8) 1.6 (0.8, 3.6) Transferrin, mg/dl 185.0 (100.0, 388.2) 192.5 (110.1, 427.5) 185.0 (101.9, 361.0) 187.4 (107.4, 389.5) Total protein, g/L 58.0 (52.7, 62.8) 56.6 (51.4, 60.8) 58.6 (54.0, 63.8) 53.3 (47.2, 62.2) Prealbumin, mg/L 316.5 (227.0, 385.0) 311.4 (234.0, 377.8) 321.0 (224.0, 390.0) 349.2 (214.0, 397.4) Fasting glucose, mmol/L 4.8 (4.3, 5.5) 4.7 (4.2, 5.4) 4.8 (4.3, 5.5) 4.6 (4.1, 5.0) Sodium, mEq/L 140.0 (137.0, 143.0) 139.8 (137.0, 142.3) 140.0 (137.6, 143.0) 140.0 (136.0, 143.0) C-reaction protein, mg/dl 2.2 (0.9, 5.0) 2.3 (0.9, 6.1) 2.1 (1.0, 4.5) 1.12 (1.01, 1.22)                 
Fig. 1. Patterns of dialysate / plasma creatinine ratios in the peritoneal equilibration 
test. Grey square dash-dot line, Latent class 1 (n=1,255, 36.1%); grey diamond dash-dot line, Latent class 2 
(n=2,127, 61.2%); black circle dash-dot line, Latent class 3 
(n=95, 2.7%). D0: dialysate creatinine at 0 hours; D2: dialysate creatinine at 2 hours; D4: dialysate creatinine at 4 hours; P: plasma creatinine at 0 hours.
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Patients in Class 2 had the highest median body mass index (22.9 kg/m2), the lowest median blood pressure measures (140 and 85 mmHg for systolic blood pressure (SBP) and diastolic blood pressure (DBP)), the highest median haemoglobin (95.0 g/L), the highest 
median total protein (58.6 g/L), and the highest eGFR (1.7ml/min/1.73m2).Patients in Class 3 had the lowest proportion of male gender (53.5%), the highest median age (51 years), the lowest prevalence of previously diagnosed cardiovascular diseases (32.6%), the highest proportion of taking antihypertensive prescriptions (46.3%), 
the highest median blood pressure measures (147.5 and 90.0 mmHg for SBP and DBP), the 
highest median haemoglobin (97.0 g/L), the highest median total iron binding capacity (49.0µmol/L), the lowest median creatinine (824.0µmol/L), the lowest median total protein (53.3g/L), the lowest median fasting glucose (4.6 mmol/L) and the median lowest CRP (1.12 mg/dl).Absolute Numbers and mortality rates with adjusted odd ratios for 2-year cardiovascular 
mortality are provided in Table 2. The 2-year mortality rate was 13.6 11.7, 15.6) %, 9.0 (7.8, 
10.3) %, and 7.4 (3.0, 14.6) % for Class 1, Class 2, and Class 3, respectively. In the most adjusted model, patients in Class 2 has a 35% decreased risk (Odds ratio (OR) 0.65 0.62, 0.69)) of cardiovascular death and 55% decreased risk of patients in Class 3 (0.45 (95 CI: 0.38, 0.54)), with comparison to patients in Class 1.
DiscussionApplying a novel latent class trajectory analysis approach, this study revealed 
heterogeneity in dialysate creatinine response to PET test. We identified three different patterns and were able to associate them to the long-term outcome, cardiovascular mortality rate. Two groups (Class 3 and 2) characterised by decreased dialysate / plasma creatinine ratio between 0- hour and 2-hour and/or low ratios at 2- and 4-hour over the PET were associated with low risks of cardiovascular mortality.
Class 3 and 2 were identified as more favourable response patterns, as patients belonging to Class 3 and Class 2 had 55% and 35% decreased risk of cardiovascular mortality comparing with those in Class 1. Intermediate time points, especially D4/P, were also found to be superior marker for all-cause mortality and hospitalisation in another study [10]. Similarly, comparing with patients in Class 1, lower D4/P was characterised among patients in Class 3 and Class 2, which was associated with lower risk of cardiovascular mortality. This might be explained by the lower proportion of existing CVD in the classes, which has been 
reported in other studies [16, 17]. This might also be due to the higher proportion of taking antihypertensive medicine in the class, which leading to the potential protection effect in the cardiovascular system [18]. We also observed the better remained kidney function in patients within Class 3 and 2 that could also play a role in the relative slow progress of 
CVD, as observed in previous study [18, 19]. The systematic inflammatory status has been proved to contribute the premature death of CVD by previous studies [20]. In our study, the 
lower level CRP (the surrogate of the systematic inflammatory) was identified in patients 
within Class 3 and Class 2. The plasma glucose level also has been proved to be a significant dominant for cardiovascular mortality among PD patients [21]. In this study, the lower level 
Table 2. Crude incidence rates and adjusted odds ratios (95% confidence interval) for cardiovascular mortality by latent class. N, number of cardiovascular deaths. Model 1: adjusted for age, and gender. Model 2: adjusted for co-variables presented in Table 1
 
2 
 
    
Class N Incidence rate (95% CI), % Odds Ratio (95% CI) Model 1 Model 2 Class 1 170 13.55 (11.70, 15.56) Reference Reference Class 2 192 9.03 (7.84, 10.33) 0.63 (0.61, 0.66) 0.65 (0.62, 0.69) Class 3 7 7.37 (3.01, 14.59) 0.48 (0.41, 0.57) 0.45 (0.38, 0.54)  
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of glucose among patients within Class 3 and Class 2 might contribute to their lower risk 
of cardiovascular mortality. Risk factors generally reflecting the general health status, like haemoglobin and prealbumin were observed higher in Class 3 and 2, all of which could also contribute to the decreased risk of cardiovascular mortality as observed in other studies [22-24]. Moreover, lower blood pressure measurements in Class 2 comparing with Class 1 might also explain the lower cardiovascular mortality in Class 2.In previous studies, one time-point Dt/P ratio was used to predict the future risk of long-term outcome [10]. However, such measurements have limitations, as individual patients with different dialysate creatinine response trajectories can still have similar values for several 
calculate curve features. Therefore, instead of studying predefined curve characteristics, we considered heterogeneity of change using the data-driven approach. Latent class trajectory analysis allows the investigation of change over time, while taking measurement error into account. Compared with conventional approaches assessing only mean growth curves, the latent class method is suitable to reveal heterogeneous patterns, which may give us a more complete picture of associations.It is notable to bear in mind that the aim of this study was not to derive the best prediction 
model or to determine optimal cut-off values for the examined outcomes, but to find associations that might not have been revealed with conventional methods. We observed that different dialysate creatinine response patterns during PET are associated with differed risks of cardiovascular mortality, which cannot be fully explained by differences in cardiometabolic 
risk profiles. This suggests that dialysate creatinine measurements at different time points 
should be considered simultaneously to get a more detailed picture of a patient’s risk of future cardiovascular mortality. One limitation aspect that needs further investigation is the difference in cardiovascular mortality rates between classes, because the event numbers in the different classes were low and we did not have enough power to examine in details which exact cause contributed to the excess cardiovascular mortality rates in Class 3 compared 
with Class 1. Moreover, our results might be influenced by confounding by unmeasured risk factors, for example, those due to under-recording of pre-existing comorbidities and their duration.  The duration of reduced renal function would be a particularly important measure prone to under-estimation. Thirdly, we lacked data on lifestyle factors, including smoking, 
drinking and physical activity. Fourthly, we did not adjust for PD patients’ socioeconomic 
status that would likely impact on PD patients’ treatment/management status and their 
general health status. Finally, the proportion of clinical measurement data that was missing was relatively high requiring multiple imputation, which suggesting that further replication in the external dataset are warranted.
ConclusionPD patients with decreased dialysate / plasma creatinine ratio between 0- hour and 2-hour and low ratios at 2- and 4-hour are more likely to have low risk of future cardiovascular 
mortality. Latent class analysis seems to be a promising method to reveal unidentified 
subgroups that do not fit into the risk category defined by dialysate / plasma creatinine ratio at 4-hour.
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